KNBIF (Kane Biotech) 3-Year Book Growth Rate: 57.50% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kane Biotech 3-Year Book Growth Rate?

Kane Biotech KNBIF -0.55% 3-Year Book Growth Rate is 57.50% as of Mar. 2026. The stock has 6 warning signs investors should review. Among 1,136 Biotechnology companies, Kane Biotech ranks better than 94.98% on this metric.

Kane Biotech's Book Value per Share for the quarter that ended in Mar. 2026 was $-0.01.

During the past 3 years, the average Book Value per Share Growth Rate was 57.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 22.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Kane Biotech was 57.50% per year. The lowest was -78.80% per year. And the median was -17.20% per year.

Kane Biotech  (OTCPK:KNBIF) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Kane Biotech 3-Year Book Growth Rate Related Terms

KNBIF vs VRTX, REGN, ALNY: 3-Year Book Growth Rate Comparison

For the Biotechnology subindustry, Kane Biotech's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech 3-Year Book Growth Rate vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Kane Biotech's 3-Year Book Growth Rate falls into.


Kane Biotech 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

What does a 3-Year Book Growth Rate of 57.50% mean?
Kane Biotech (KNBIF) has a 3-Year Book Growth Rate of 57.50% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #57 out of 1136 companies in the Biotechnology industry, placing it in the top 5%.
Is Kane Biotech's 3-Year Book Growth Rate too high?
Kane Biotech's current 3-Year Book Growth Rate is 57.50%. Based on the distribution chart, Kane Biotech ranks #57 out of 1136 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Kane Biotech's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #57 out of 1136 companies for 3-Year Book Growth Rate. This places Kane Biotech in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Kane Biotech and its competitors. Kane Biotech's current 3-Year Book Growth Rate is 57.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current 3-Year Book Growth Rate of 57.50%. The current 3-Year Book Growth Rate is 57.50%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current 3-Year Book Growth Rate is 57.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.